Chenguang Biotech Group
ChenGuang Biotech Group Co., Ltd. develops and produces natural colors, spice extracts and essential oils, nutritional and pharmaceutical extracts, and oils and protein. The company offers natural colors, including paprika oleoresin, marigold oleoresin, and turmeric; spice extracts and essential oils, such as capsicum oleoresin, sichuan pepper oil, pepper oleoresin, ginger extract, and cumin oleo… Read more
Chenguang Biotech Group (300138) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.155x
Based on the latest financial reports, Chenguang Biotech Group (300138) has a cash flow conversion efficiency ratio of 0.155x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥524.96 Million) by net assets (CN¥3.39 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Chenguang Biotech Group - Cash Flow Conversion Efficiency Trend (2007–2024)
This chart illustrates how Chenguang Biotech Group's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Chenguang Biotech Group Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Chenguang Biotech Group ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
XiAn Tian He Defense Technology Co Ltd
SHE:300397
|
-0.012x |
|
Suzhou TZTEK Technology Co Ltd
SHG:688003
|
0.001x |
|
Schrödinger, Inc.
F:43Z
|
-0.193x |
|
Guizhou Broadcasting&TV Info
SHG:600996
|
0.053x |
|
Zhongnongfa Seed Industry Group Co Ltd
SHG:600313
|
-0.022x |
|
NewtekOne, Inc. 8.50% Fixed Rate Senior Notes due 2031
NASDAQ:NEWTO
|
N/A |
|
Antar Chile
SN:ANTARCHILE
|
0.005x |
|
Xencor Inc
NASDAQ:XNCR
|
-0.049x |
Annual Cash Flow Conversion Efficiency for Chenguang Biotech Group (2007–2024)
The table below shows the annual cash flow conversion efficiency of Chenguang Biotech Group from 2007 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥3.15 Billion | CN¥-222.81 Million | -0.071x | +51.17% |
| 2023-12-31 | CN¥3.53 Billion | CN¥-510.91 Million | -0.145x | -163.27% |
| 2022-12-31 | CN¥3.21 Billion | CN¥734.81 Million | 0.229x | +895.84% |
| 2021-12-31 | CN¥2.78 Billion | CN¥63.90 Million | 0.023x | -91.07% |
| 2020-12-31 | CN¥2.06 Billion | CN¥529.41 Million | 0.257x | +1938.29% |
| 2019-12-31 | CN¥1.74 Billion | CN¥-24.35 Million | -0.014x | +56.69% |
| 2018-12-31 | CN¥1.74 Billion | CN¥-56.18 Million | -0.032x | +64.08% |
| 2017-12-31 | CN¥1.62 Billion | CN¥-145.95 Million | -0.090x | +57.39% |
| 2016-12-31 | CN¥1.52 Billion | CN¥-321.62 Million | -0.211x | -365.52% |
| 2015-12-31 | CN¥1.43 Billion | CN¥-64.66 Million | -0.045x | -116.74% |
| 2014-12-31 | CN¥1.01 Billion | CN¥272.96 Million | 0.271x | +835.08% |
| 2013-12-31 | CN¥990.39 Million | CN¥-36.47 Million | -0.037x | +74.15% |
| 2012-12-31 | CN¥997.86 Million | CN¥-142.11 Million | -0.142x | -267.87% |
| 2011-12-31 | CN¥968.71 Million | CN¥82.18 Million | 0.085x | +141.55% |
| 2010-12-31 | CN¥933.05 Million | CN¥-190.51 Million | -0.204x | -257.95% |
| 2009-12-31 | CN¥210.67 Million | CN¥27.23 Million | 0.129x | +111.04% |
| 2008-12-31 | CN¥147.93 Million | CN¥9.06 Million | 0.061x | +127.06% |
| 2007-12-31 | CN¥101.70 Million | CN¥-23.02 Million | -0.226x | -- |